<ul>
 <li>A host of awareness programs targeting children to be held in the French Pavilion, from 4 to 7 March</li>
 <li>An event full of entertainment to be held in conjunction with the 100th anniversary of insulin's discovery</li>
 <li>Since its launch in 2016, KiDS program trained 57,284 students in 183 schools, 4,117 teachers, 3,045 parents and 188 school nurses across the country</li>
</ul>

The Ministry of Health and Prevention (MohAP) will organize at the French Pavilion, Expo 2020 Dubai several activities and events as part of the Kids and Diabetes in Schools (KiDS) program, in cooperation with the Ministry of Education and Sanofi, an innovative global healthcare company.
Running from 4-7 March, the activities are coinciding with the 100th anniversary of insulin discovery, the medicine which made a huge difference in the daily living of patients.
Since its launch in 2016, the KiDS program has covered 183 schools with 57,284 students and has trained 4,117 teachers, 3,045 parents and 188 school nurses across the UAE, in addition to handing out 60,000 booklets to children, schools and families.

<h2>Fostering preventive patterns&nbsp;&amp; behaviors</h2>
"Organizing such activities of the KiDS program is part of the ministry' awareness initiatives aimed at fostering preventive behaviors among children, upbringing healthy generations and securing their psychological and physical safety and improving healthcare standards as per the best international practices," said HE Dr. Hussain Abdul Rahman Al Rand, Assistant Undersecretary for the Public Health Sector at the Ministry of Health and Prevention.
"We are glad to organize the KiDS program with students. The program highlights the importance of creating a positive environment helping children with diabetes manage their condition using the best and most effective protocols," added Al Rand.
He stated that organizing the activities at such a global event, Expo 2020 Dubai, would help expand the positive impact of the program on children and society, as well as stimulate international dialogue for better progress and cooperation in the global fight against diabetes.

<h2>Top priority</h2>
Al Rand underscored that the ministry pays top priority to the planning and implementation of diabetes-related health awareness paths, especially for students, in coordination with health and educational bodies, highlighting the importance of cooperation with the International Diabetes Federation and Sanofi carry out the KiDS program, which is part of the ministry's strategy to establish a sustainable health environment according to locally and internationally effective partnerships and programs.
Kids and Diabetes in Schools (KiDS) was launched in 2013 by the International Diabetes Federation (IDF), the International Society for Pediatric and Adolescent Diabetes (ISPAD), and Sanofi
In 2016, the UAE has adopted the KiDS program to prevent diabetes type 2, address the symptoms of diabetes type 1, and spread healthy habits among students across the country.

<h2>Healthy future for Children</h2>
"We are pleased to continue this collaboration with the IDF and ISPAD during the years of implementing the KiDS project on a global scale," said Niven Al-Khoury, General Manager General Medicines at Sanofi KSA and Gulf Countries. "On the local level, working with the UAE's Ministries of Health and Education to implement the program across the UAE demonstrates our firm commitment to implementing our vision for a healthy future for all children in the country.
The activities include an entertaining game, with the official "Tanton" character for the KiDS program, which welcomes children and helps them throughout the journey. Also, giant screens are also available displaying interesting information about diabetes, including ways of prevention and living with it. Once visitors to the booth complete all the necessary stickers and seals, they will be rewarded bags containing a sketch booklet on diabetes prevention, and eco-friendly notebooks "made of recycled paper".

<h2>See this article in media</h2>
<ul>
 <li><a href="https://protect-de.mimecast.com/s/p3xNCQkoEgs6Y4yYytxJHF4?domain=bodhi-production-assets.s3.amazonaws.com)" target="_blank">Dubai 93 FM Radio</a></li>
 <li><a href="https://www.youtube.com/watch?v=XZ1g7AwJJZM)" target="_blank">Al Ain TV</a></li>
 <li><a href="https://www.youtube.com/watch?v=589-nFf-UHs" target="_blank">Video</a></li>
</ul>
Online:
<ul>
 <li><a href="https://www.albayan.ae/expo/news/2022-03-04-1.4383899" target="_blank">Al Bayan Newspaper</a></li>
 <li><a href="https://wam.ae/ar/details/1395303026753" target="_blank">Emirates News Agency (WAM)</a></li>
 <li><a href="https://www.zawya.com/en/press-release/events-and-conferences/ministry-of-health-organizes-kids-program-at-expo-2020-dubai-to-promote-diabetes-awareness-at-schools-mh6flggp" target="_blank">Zawya - English</a></li>
 <li><a href="https://al-ain.com/article/expo-2020-dubai-kids-diabetes" target="_blank">Al Ain TV online</a></li>
 <li><a href="https://nabd.com/s/101035634-40d2b3/%D8%A5%D9%83%D8%B3%D8%A8%D9%88-2020-%D8%AF%D8%A8%D9%8A..-%D9%83%D9%8A%D8%AF%D8%B2-%D9%8A%D8%B9%D8%B2%D8%B2-%D9%88%D8%B9%D9%8A-%D8%B7%D9%84%D8%A7%D8%A8-%D8%A7%D9%84%D9%85%D8%AF%D8%A7%D8%B1%D8%B3-%D8%A8%D9%85%D8%B1%D8%B6-%D8%A7%D9%84%D8%B3%D9%83%D8%B1%D9%8A" target="_blank">NABD</a></li>
 <li><a href="https://alwatan.ae/?p=932642" target="_blank">Al Watan Newspaper</a></li>
</ul>

Ministry of Health organizes "KiDS" program at Expo 2020 Dubai to promote diabetes awareness at schools

OTHER-TOPICS

OUT-OF-TAXONOMY

<ul>
 <li>Agreement aims to provide more advanced and effective treatments and revitalised research and development (R&amp;D) in the field of diabetes in Saudi Arabia</li>
 <li>Strategic deal covers the rollout of training courses and workshops for medical doctors and diabetes educators with specific criteria and performance indicators</li>
</ul>

The Saudi Health Council, represented by the National Diabetes Centre, signed a memorandum of understanding (MoU) with Sanofi, to collaborate on various initiatives in research and development in the field of diabetes in the kingdom.
In the presence of Dr Nahar bin Mazki Al-Azmi, Secretary-General of the Saudi Health Council, and Dr Moatazbellah bin Muhammad Alruwaithi, Assistant Secretary-General, Dr Suleiman bin Nasser Alshehri, Director General of Saudi Diabetes Centre, Tarja Stenvall, Senior Vice President, General Medicines Key Markets, Sanofi and Niven Al- Khoury, General Manager General Medicines KSA &amp; Gulf MCO at Sanofi, the event has been held at the headquarters of the General Secretariat of the Council.
“This collaboration will serve as a great impetus in offering efficient healthcare initiatives to develop the ecosystem of diabetes management in the country. Sanofi and SHC will collaborate in building the nucleus of scientific research and generating disease local data supported by establishing a comprehensive diabetes research network. In addition, the agreement includes launching a digital tool that aim to improve the efficiency of diabetes management among people living with diabetes in the country. This MoU will include collaboration in the development and implementation of tailored training courses and workshops for physicians and diabetes educators with specific criteria and performance indicators.” Dr. Al-Shehri said.
Dr. Al-Shehri acknowledges Sanofi’s effort in supporting scientific research, enhancing disease management capabilities, and patients awareness programs. He also conveyed his desire for continued effective and successful cooperation in the future between the two entities, in order to further improve the country’s healthcare sector.
Meanwhile, Tarja Stenvall, Senior Vice President, General Medicines Key Markets, Sanofi, welcomed the collaboration and highlighted its substantial role in facilitating comprehensive, high-quality healthcare to people living with diabetes.
“Drawing on our unrivalled experience in the fight against diabetes, we are implementing a series of strategic projects in the healthcare sector of Saudi Arabia. We’re grateful to the Saudi Health Council for its sustained efforts in coordination with various authorities to prevent and control diabetes as part of its commitment to bolster the country’s public health.” Tarja Stenvall, said

<h2>Read this article in media</h2>
<a href="https://www.arabianbusiness.com/abnews/saudi-health-council-sanofi-partner-to-boost-diabetes-studies-and-research" target="_blank">Arab Business</a>
<a href="https://www.zawya.com/mena/en/press-releases/story/Saudi_Health_Council_Sanofi_partner_to_boost_diabetes_studies_and_research_in_the_kingdom-ZAWYA20220118133557/" target="_blank">Zawaya</a>
<a href="https://saudigazette.com.sa/article/616014" target="_blank">Saudi Gazette</a>
<a href="https://worldakkam.com/shc-sanofi-partners-support-diabetes-research-and-kingdom-research/657032/" target="_blank">World Akkam</a>
<a href="https://sawahpress.com/en/business/shc-sanofi-partner-to-boost-diabetes-studies-and-research-in-kingdom/" target="_blank">Sawah Press</a>

Saudi Health Council, Sanofi partner to boost diabetes studies and research in the kingdom

To read the full content, activate your Sanofi Campus account. Please confirm your email address in the email you received.

If you didn't receive our first email at {email} to confirm your account you can request a new one below. If you don't see it, you may need to check your spam folder.

This information will only be used to validate your account and will not be distributed.

title

Before starting exploring, we can suggest you specific and relevant content

Title

This website is for healthcare professionals only.

Welcome to BP Sanofi Campus

Create new password

To offer you a personalised experience, you must

Your profile is incomplete

The ADCT gives a measure of how controlled the eczema is. Answer these 6 simple questions with your patient to find the ADCT score. It will indicate proper course of action.

Atopic dermatitis, a type of eczema, may be affecting your Patient's life in more ways than you know.

Take the Atopic Dermatitis Control Test (ADCT)

Enjoy more exclusive content{newline}by <a>registering today</a>

Already have an account? <a>Sign in here</a>

Best practices on optimising patient care

Get a customised view of the topics that you're interested in, along with the ability to save content to watch or read at a later date.

Unlimited access to premier content, white papers, case studies, research papers, webinars, training, and up-to-date scientific medical resources.

Personalised content based on your areas of interest

Connect and stay up-to-date with peers in your area of speciality and topics of interest through free events and leadership forums.

Please sign in to continue and read the full article

Please sign up to continue reading the full article.

We respect your privacy and will not share your information with any 3rd parties.

Topical guides written specifically for patients

Unlimited access to the latest patient guide guides and resources. Share content with your patients with easy-to-use online tools.

Please complete your profile to read the content.

Your profile is not validated yet. Please verify your inbox.

Restricted Access

We can't find the page you're looking for

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

You are about to leave Sanofi Campus website.

You are now leaving this site to visit a partner website.

Thank you for visiting COPD Sanofi Campus.

Welcome to COPD Sanofi Campus.

Welcome to COPD Sanofi Campus

Welcome to CSU Sanofi Campus

Please refresh the page to access the content

Sorry, something went wrong

We're usually a treasure chest of knowledge, but we couldn't find what you're looking for.

We were unable to find what you're searching for

You are about to leave Campus.sanofi/uk.

Images from <a>iStockphoto.com</a>, Fotolia.de, <c>gettyimages.de</c>, <d>pexels.com</d> and <e>photocase.de</e> were used for our websites.

Thank you for registering. Before we get started, we need to confirm your email address to ensure that we have the correct information.

Please follow these steps to complete your registration:

Would you like to receive future text messages about Beyfortus updates?

Sanofi is here to help support your patients, their families, and caregivers. For more information regarding Beyfortus®, call <a.callPhoneNumberBeyfortus>1-855-BEYFORTUS (1-855-239-3678)</a.callPhoneNumberBeyfortus> or sign up below to receive the latest updates via email or text. All fields are required.

Would you like to learn more about Beyfortus® (nirsevimab-alip) 50 mg and 100 mg injection? Leave us your contact details, and a Sanofi representative will be in touch. All fields are required.

Would you also like to receive future messages and updates about Beyfortus?

Do you want to participate in the Beyfortus Reservation Program?

What information are you interested in learning more about? (Optional)

Are you enrolled in CENRIFKI REMS?

Request a visit from your local ALPROLIX representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local ALTUVIIIO representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Request a visit from your local QFITLIA representative to learn more. Call <a.callPhoneNumberAltuviiio>1-800-745-4447</a.callPhoneNumberAltuviiio>, Option 5, or complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your ALPROLIX® Representative or receive updates about ALPROLIX. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required.

Sign up to schedule an office visit with your local Sanofi representative and/or to receive updates about Qfitlia. Please complete the form below. The information you provide will be maintained in accordance with our <a.usPrivacyPolicy>Privacy Policy</a.usPrivacyPolicy>. All fields are required (unless otherwise specified).

All fields are required. (unless otherwise specified)

This site is intended for healthcare professionals only and contains information on Sanofi medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a healthcare professional. This site contains promotional information. Please note that some of the content on the website is only relevant for HCPs.

Welcome to Sanofi Campus

Welcome to ITP Sanofi Campus

This content is only available to registered users. Please sign in or register to view this content.

Please Sign In

Email verification

You're seeing a preview of the portal. Clear your cookies (by closing your browser window for example) to go back to public mode.

We've updated our privacy notice to better protect your data and enhance your experience. Please take a moment to review the changes by <privacyNewTab>clicking here</privacyNewTab>. Your privacy matters for us. Please click on continue to confirm you have read the new privacy notice.

Privacy Notice Update

Communication consent

My consents

Password

Confirm password

{resultsCount, plural, one {result} other {results}}

Please log in to access to the results

You need to sign-in to your account in order to access medical content.

Please Log In

To access the results, please register in under 1 minute

You are now leaving the Sanofi content section of our site and entering the external medical bibliographic search content section.

You are entering to the External Scientific Content Site

You are now leaving the external medical bibliographic search section of our site and entering the Sanofi content section.

Other Topics

Latest Articles

Ministry of Health organizes "KiDS" program at Expo 2020 Dubai to promote diabetes awareness at schools

Saudi Health Council, Sanofi partner to boost diabetes studies and research in the kingdom